HETEROCYCLIC DERIVATIVES
The present invention relates to a heterocyclic derivative according to formula I wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceutical composition comprising said heterocyclic de...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MOIR ELIZABETH MARGARET JAMIESON CRAIG LYONES AMANDA JANE MACLEAN JOHN KINNAIRD FERGUSON GALLAGHER MICHAEL GERARD |
| description | The present invention relates to a heterocyclic derivative according to formula I wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceutical composition comprising said heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of psychiatric diseases where an enhancement of synaptic responses mediated by AMPA receptors is required, including schizophrenia, depression and learning and memory disorders such as Alzheimer's disease. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA201002580B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA201002580B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA201002580B3</originalsourceid><addsrcrecordid>eNrjZJDwcA1xDfJ3jnT28XRWcHEN8gxzDPEMcw3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxUY5GBoYGBkamFgZOxsSoAQAGIx_d</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HETEROCYCLIC DERIVATIVES</title><source>esp@cenet</source><creator>MOIR ELIZABETH MARGARET ; JAMIESON CRAIG ; LYONES AMANDA JANE ; MACLEAN JOHN KINNAIRD FERGUSON ; GALLAGHER MICHAEL GERARD</creator><creatorcontrib>MOIR ELIZABETH MARGARET ; JAMIESON CRAIG ; LYONES AMANDA JANE ; MACLEAN JOHN KINNAIRD FERGUSON ; GALLAGHER MICHAEL GERARD</creatorcontrib><description>The present invention relates to a heterocyclic derivative according to formula I wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceutical composition comprising said heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of psychiatric diseases where an enhancement of synaptic responses mediated by AMPA receptors is required, including schizophrenia, depression and learning and memory disorders such as Alzheimer's disease.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101229&DB=EPODOC&CC=ZA&NR=201002580B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101229&DB=EPODOC&CC=ZA&NR=201002580B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MOIR ELIZABETH MARGARET</creatorcontrib><creatorcontrib>JAMIESON CRAIG</creatorcontrib><creatorcontrib>LYONES AMANDA JANE</creatorcontrib><creatorcontrib>MACLEAN JOHN KINNAIRD FERGUSON</creatorcontrib><creatorcontrib>GALLAGHER MICHAEL GERARD</creatorcontrib><title>HETEROCYCLIC DERIVATIVES</title><description>The present invention relates to a heterocyclic derivative according to formula I wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceutical composition comprising said heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of psychiatric diseases where an enhancement of synaptic responses mediated by AMPA receptors is required, including schizophrenia, depression and learning and memory disorders such as Alzheimer's disease.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDwcA1xDfJ3jnT28XRWcHEN8gxzDPEMcw3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxUY5GBoYGBkamFgZOxsSoAQAGIx_d</recordid><startdate>20101229</startdate><enddate>20101229</enddate><creator>MOIR ELIZABETH MARGARET</creator><creator>JAMIESON CRAIG</creator><creator>LYONES AMANDA JANE</creator><creator>MACLEAN JOHN KINNAIRD FERGUSON</creator><creator>GALLAGHER MICHAEL GERARD</creator><scope>EVB</scope></search><sort><creationdate>20101229</creationdate><title>HETEROCYCLIC DERIVATIVES</title><author>MOIR ELIZABETH MARGARET ; JAMIESON CRAIG ; LYONES AMANDA JANE ; MACLEAN JOHN KINNAIRD FERGUSON ; GALLAGHER MICHAEL GERARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA201002580B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MOIR ELIZABETH MARGARET</creatorcontrib><creatorcontrib>JAMIESON CRAIG</creatorcontrib><creatorcontrib>LYONES AMANDA JANE</creatorcontrib><creatorcontrib>MACLEAN JOHN KINNAIRD FERGUSON</creatorcontrib><creatorcontrib>GALLAGHER MICHAEL GERARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MOIR ELIZABETH MARGARET</au><au>JAMIESON CRAIG</au><au>LYONES AMANDA JANE</au><au>MACLEAN JOHN KINNAIRD FERGUSON</au><au>GALLAGHER MICHAEL GERARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HETEROCYCLIC DERIVATIVES</title><date>2010-12-29</date><risdate>2010</risdate><abstract>The present invention relates to a heterocyclic derivative according to formula I wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceutical composition comprising said heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of psychiatric diseases where an enhancement of synaptic responses mediated by AMPA receptors is required, including schizophrenia, depression and learning and memory disorders such as Alzheimer's disease.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_ZA201002580B |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | HETEROCYCLIC DERIVATIVES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T08%3A47%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MOIR%20ELIZABETH%20MARGARET&rft.date=2010-12-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA201002580B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |